Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia Article Swipe
Related Concepts
Daniel L. Rolnik
,
D. Wright
,
Liona C. Poon
,
N. O’Gorman
,
Argyro Syngelaki
,
C. de Paco Matallana
,
Ranjit Akolekar
,
S. Cicero
,
D. Janga
,
Mandeep Singh
,
Francisca S. Molina
,
Nicola Persico
,
Jacques Jani
,
W. Plasencia
,
George Papaioannou
,
Kinneret Tenenbaum-Gavish
,
Hamutal Meiri
,
Sveinbjörn Gizurarson
,
Kate Maclagan
,
K. H. Nicolaides
·
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1056/nejmoa1704559
· OA: W2730504020
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1056/nejmoa1704559
· OA: W2730504020
Treatment with low-dose aspirin in women at high risk for preterm preeclampsia resulted in a lower incidence of this diagnosis than placebo. (Funded by the European Union Seventh Framework Program and the Fetal Medicine Foundation; EudraCT number, 2013-003778-29 ; Current Controlled Trials number, ISRCTN13633058 .).
Related Topics
Finding more related topics…